Clinical trial
The Impact of Adipose Tissue Insulin Resistance and Abdominal Obesity on Hepatic Fatty Acid Metabolism in Type 1 Diabetes
NCT07133854 is registered in ClinicalTrials.gov with Université de Sherbrooke as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Impact of Adipose Tissue Insulin Resistance and Abdominal Obesity on Hepatic Fatty Acid Metabolism in Type 1 Diabetes
- Lead sponsor
- Université de Sherbrooke
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- September 30, 2026
- Completion date
- December 31, 2028
- Enrollment
- 32 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
metabolic dysfunction-associated steatotic liver disease, non-alcoholic steato-hepatitis (nash), type 1 diabetes mellitus